Glucotypes reveal new patterns of glucose dysregulation

PLoS Biology

Volumn 16, Issue 7, 2018, Pages

  Hall, Heather ^a,b   Perelman, Dalia ^b   Breschi, Alessandra ^b   Limcaoco, Patricia ^b   Kellogg, Ryan ^b   McLaughlin, Tracey ^c   Snyder, Michael ^b  

^a Stanford California and Cofounder   (United States)

^b STANFORD UNIVERSITY   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CARBOHYDRATE ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE CLASSIFICATION; DISORDERS OF CARBOHYDRATE METABOLISM; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE DYSREGULATION; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLUCOTYPE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN METABOLISM; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; TIME SERIES ANALYSIS; BLOOD; CARBOHYDRATE METABOLISM; HOMEOSTASIS; HYPERGLYCEMIA; INTERNET; MEAL; METABOLISM; MIDDLE AGED;

ADULT; AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CARBOHYDRATE METABOLISM; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HOMEOSTASIS; HUMANS; HYPERGLYCEMIA; INSULIN; INTERNET; MALE; MEALS; MIDDLE AGED;

EID: 85051292787     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.2005143     Document Type: Article

References (42)

1. American Diabetes AssociationAmerican Diabetes Association Standards of Medical Care in Diabetes—2017. Diabetes Care—The Journal of Clinical and Applied Research and Education. 2016;40 (Supplement 1) p. 1–142.
2. Tabá G, Herder C, Rathmann W, Brunner E, Kivimäk M, Prediabetes: A High-Risk State for Developing Diabetes. The Lancet. 2012;379(9833):2279–2290.
3. McCulloch DK, Overview of medical care in adults with diabetes mellitus. UpToDate Online Boston. 2009. Available from: https://www.uptodate.com/contents/overview-of-medical-care-in-adults-with-diabetes-mellitus
4. Ahlqvist E, Storm P, Käräjämäki A, Martinell M, Dorkhan M, Carlsson A, et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. The Lancet Diabetes and Endocrinology. 2018; 6(5):361–369doi: 10.1016/S2213-8587(18)30051-2 pmid: 29503172
5. Holst JJ, Knop FK, Vilsbøll T, Krarup T, Madsbad S, Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetes. Diabetes Care. 2011;34(Supplement 2):S251–S257.
6. Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, et al. Impaired Fasting Glucose and Impaired Glucose Tolerance. Diabetes Care. 2007;30(3):753–759. doi: 10.2337/dc07-9920 pmid: 17327355
7. Group DPPRReduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England journal of medicine. 2002;346(6):393–403. doi: 10.1056/NEJMoa012512 pmid: 11832527
8. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance. New England Journal of Medicine2001;344(18):1343–1350. doi: 10.1056/NEJM200105033441801 pmid: 11333990
9. Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. The Lancet. 2008;371(9626):1783–1789.
10. Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, et al. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Annals of internal medicine. 2005;142(5):323–332. pmid: 15738451
11. Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A, et al. Personalized Nutrition by Prediction of Glycemic Responses. Cell. 2015;163(5):1079–1094. doi: 10.1016/j.cell.2015.11.001 pmid: 26590418
12. Borg R, Kuenen J, Carstensen B, Zheng H, Nathan D, Heine R, et al. Real-life glycaemic profiles in non-diabetic individuals with low fasting glucose and normal HbA1c: the A1C-Derived Average Glucose (ADAG) study. Diabetologia. 2010;53(8):1608–1611. doi: 10.1007/s00125-010-1741-9 pmid: 20396998
13. Garber AJ, Postprandial dysmetabolism and the heart. Heart failure clinics. 2012;8(4):563–573. doi: 10.1016/j.hfc.2012.06.004 pmid: 22999240
14. Lind M, Tuomilehto J, Uusitupa M, Nerman O, Eriksson J, Ilanne-Parikka P, et al. The association between HbA1c, fasting glucose, 1-hour glucose and 2-hour glucose during an oral glucose tolerance test and cardiovascular disease in individuals with elevated risk for diabetes. PLoS ONE. 2014;9(10):e109506. doi: 10.1371/journal.pone.0109506 pmid: 25285769
15. Bonora E, Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives. International journal of clinical practice Supplement. 2002;(129):5–11. pmid: 12166607
16. Jung HS, Clinical Implications of Glucose Variability: Chronic Complications of Diabetes. Endocrinology and Metabolism. 2015;30(2):167. doi: 10.3803/EnM.2015.30.2.167 pmid: 26194076
17. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295(14):1681–1687. doi: 10.1001/jama.295.14.1681 pmid: 16609090
18. Crenier L, Abou-Elias C, Corvilain B, Glucose Variability Assessed by Low Blood Glucose Index Is Predictive of Hypoglycemic Events in Patients With Type 1 Diabetes Switched to Pump Therapy. Diabetes Care. 2013;36(8):2148–2153. doi: 10.2337/dc12-2058 pmid: 23404296
19. Monnier L, Colette C, Leiter L, Ceriello A, Hanefeld M, Owens D, et al. The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care. 2007;30(1):185–6– author reply 187–8.
20. Suh S, Kim JH, Glycemic Variability: How Do We Measure It and Why Is It Important?Diabetes & metabolism journal. 2015;39(4):273.
21. Albert A, Rajagopal R, Smart Meter Driven Segmentation: What Your Consumption Says About You. IEEE Transactions on Power Systems. 2013;28(4):4019–4030.
22. Tuzcu V, Nas S, Dynamic time warping as a novel tool in pattern recognition of ECG changes in heart rhythm disturbances. IEEE International Conference on Systems, Man and Cybernetics, 2005, pp. 182–186 Vol. 1. doi: 10.1109/ICSMC.2005.1571142
23. Mazze RS, Strock E, Wesley D, Borgman S, Morgan B, Bergenstal R, et al. Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis. Diabetes technology & therapeutics. 2008;10(3):149–159.
24. Nomura K, Saitoh T, Kim GU, Yamanouchi T, Glycemic profiles of healthy individuals with low fasting plasma glucose and HbA1c. ISRN endocrinology. 2011;2011(435047):6. http://dx.doi.org/10.5402/2011/435047.
25. Hovorka R, Soons PA, Young MA, ISEC: a program to calculate insulin secretion. Computer methods and programs in biomedicine. 1996;50(3):253–264. pmid: 8894385
26. Chang W, Cheng J, Allaire J, Xie Y, McPherson J. shiny: Web Application Framework for R; 2018 [cited 2018 June 28]. Available from: https://CRAN.R-project.org/package=shiny.
27. Pei D, Jones CN, Bhargava R, Chen YD, Reaven G, Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test. Diabetologia. 1994;37(8):843–845. pmid: 7988789
28. Greenfield M, Doberne L, Kraemer F, Tobey T, Reaven G, Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes. 1981;30(5):387–392. pmid: 7014307
29. Van Cauter E, Mestrez F, Sturis J, Polonsky KS, Estimation of insulin secretion rates from C-peptide levels: comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes. 1992;41(3):368–377. pmid: 1551497
30. Zhao et al. Systematic Clustering of Transcription Start Site Landscapes. PLoS ONE. 2011;6(8): e23409. http://dx.plos.org/10.1371/journal.pone.0023409doi: 10.1371/journal.pone.0023409 pmid: 21887249
31. Calinski T, Harabasz J, A dendrite method for cluster analysis. Communications in Statistics. 1974;3(1):1–27.
32. Halkidi M, Batistakis Y, Vazirgiannis M, On clustering validation techniques. Journal of intelligent information systems. 2001;17(2–3):107–145.
33. Hennig C. fpc: Flexible Procedures for Clustering; 2018 [cited 2018 June 28]. Available from: https://CRAN.R-project.org/package=fpc.
34. Batista GE, Wang X, Keogh EJ, A complexity-invariant distance measure for time series. In: Proceedings of the 2011 SIAM international conference on data mining. April28–30, 2011. Arizona, USASIAM; p. 699–710. https://doi.org/10.1137/1.9781611972818.60
35. Giorgino T, et al. Computing and visualizing dynamic time warping alignments in R: the dtw package. Journal of statistical Software. 2009;31(7):1–24.
36. Von Luxburg U, A tutorial on spectral clustering. Statistics and Computing. 2007;17(4).
37. David Meyer and Christian Buchta (2018). proxy: Distance and Similarity Measures. R package version 0.4–22. Available from: https://CRAN.R-project.org/package=proxy
38. Bersch SD, Azzi D, Khusainov R, Achumba IE, Ries J, Sensor data acquisition and processing parameters for human activity classification. Sensors (Basel, Switzerland). 2014;14(3):4239–4270.
39. Wang B, Mezlini AM, Demir F, Fiume M, Tu Z, Brudno M, et al. Similarity network fusion for aggregating data types on a genomic scale. Nature methods. 2014;11(3):333. doi: 10.1038/nmeth.2810 pmid: 24464287
40. Wojcicki JM, “J”-index. A new proposition of the assessment of current glucose control in diabetic patients. Hormone and metabolic research. 1995;27(1):41–42. pmid: 7729793
41. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF, Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes. 1970;19(9):644–655. pmid: 5469118
42. Baghurst PA, Calculating the mean amplitude of glycemic excursion from continuous glucose monitoring data: an automated algorithm. Diabetes technology & therapeutics. 2011;13(3):296–302.